Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colorectal Cancer and Advanced Precancerous Neoplasm Screening Using Stool DNA-based SDC2 and SFRP2 Methylation Test in China, a Multi-Center Study

NCT04515082 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT04515082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04515082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colorectal Cancer and Advanced Precancerous Neoplasm Screening Using Stool DNA-based SDC2 and SFRP2 Methylation Test in China, a Multi-Center Study
Lead sponsor
Changhai Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2020
Completion date
August 31, 2021
Enrollment
4,800 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adenoma, adenomatous polyps, advanced adenoma, colorectal cancer, colorectal neoplasm, serrated polyp